In fact, the analysis of the expression of enzymes of metabolism revealed that the alteration of mitochondria is a most evident target in lung adenocarcinomas, and both the catalytic subunit of ATP synthase (β-F1-ATPase) and IF1, provide two most relevant biomarkers of metastatic disease. This evidence concerns the gene ATP5IF1 and metastatic neoplasm.